Product Information
ACITRETIN 17.5 MG CAPSULE is a generic product labeled by Sigmapharm Laboratories LLC, priced at $5.4117 per EA under NDC 42794008108. Its NADAC has been published 113 times since Sep 2, 2015.
Strength
17.5 mg/1
Manufacturer
Sigmapharm Laboratories LLCNDC
42794008108
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACITRETINApproval Type
Generic (ANDA)
FDA Application
ANDA204633On Market Since
9/16/2015
Pharmacological Classes
Price Statistics
The NADAC for ACITRETIN 17.5 MG CAPSULE has been published 113 times since Sep 2, 2015, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4117 per EA |
|---|---|
| All-time high | $24.1687 (Mar 16, 2016) |
| All-time low | $4.9683 (Aug 20, 2025) |
| 52-week high | $7.9486 |
| 52-week low | $4.9683 |
| Median price | $8.9516 |
| Average price | $12.0857 |
| Largest weekly change | +55.6% (Jan 21, 2026) |
| Weeks tracked | 113 |
| Tracking since | Sep 2, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ACITRETIN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ACITRETIN 17.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 17.5 MG CAPSULE, manufactured by Sigmapharm Laboratories LLC, is $5.4117 per EA (NDC 42794008108), effective Jun 24, 2026.
How has the price of ACITRETIN 17.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACITRETIN 17.5 MG CAPSULE has declined 77.6%. It has been tracked across 113 weekly CMS publications since Sep 2, 2015.
What are the highest and lowest recorded NADAC prices for ACITRETIN 17.5 MG CAPSULE?
Since Sep 2, 2015, the NADAC for ACITRETIN 17.5 MG CAPSULE has ranged from a low of $4.9683 (Aug 20, 2025) to a high of $24.1687 (Mar 16, 2016), with a median of $8.9516 per EA.
Are there cheaper alternatives to ACITRETIN 17.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ACITRETIN 17.5 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures ACITRETIN 17.5 MG CAPSULE?
ACITRETIN 17.5 MG CAPSULE (NDC 42794008108) is labeled by Sigmapharm Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification